IMVT
Immunovant
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
IMVT fundamentals
Immunovant (IMVT) released its earnings on May 29, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -0.64 (YoY -23.08%), missed estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.64
-23.08%
Report date
May 29, 2025
Earnings Call
9:30 AM on May 30, 2025
Meeting link.EPS
Revenue
Revenue & Expenses
Key Indicators
Immunovant (IMVT) key financial stats and ratios, covering profitability, financial health, and leverage.
Immunovant (IMVT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Immunovant (IMVT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Immunovant (IMVT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Immunovant (IMVT) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Immunovant (IMVT) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Immunovant’s latest dividend and current dividend yield?What were the key takeaways from Immunovant’s earnings call?What factors drove the changes in Immunovant’s revenue and profit?What guidance did Immunovant’s management provide for the next earnings period? What does Immunovant do and what are its main business segments?What is the revenue and EPS growth rate for Immunovant year over year?How were Immunovant’s latest financial results overall?What is the market’s earnings forecast for Immunovant next quarter?